$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Home
Hepatobiliary
Hepatobiliary
乙肝妈妈可以母乳喂养婴儿
2025-10-19 11:44:20
Check Details
慢性乙型肝炎患者的肝细胞癌风险因素和确诊年龄
2025-10-19 11:44:20
Check Details
替诺福韦的缺陷已被替诺福韦艾拉酚胺完全弥补
2025-10-19 11:44:20
Check Details
妊娠期使用替诺福韦,乙肝母婴传播风险降低
2025-10-19 11:44:20
Check Details
恩替卡韦和替诺福韦降低肝细胞癌风险哪个强?
2025-10-19 11:44:20
Check Details
乙肝患者治疗误区
2025-10-19 11:44:20
Check Details
替诺福韦(TDF)说明书
2025-10-19 11:44:20
Check Details
孕妇适不适合服用替诺福韦二代?
2025-10-19 11:44:20
Check Details
乙肝相关肝硬化接受抗病毒治疗显著降低死亡率肝癌发病率
2025-10-19 11:44:20
Check Details
乙肝病毒是肝癌的重要杀手
2025-10-19 11:44:20
Check Details
年轻肝病患者(50岁以下)肝癌风险较高
2025-10-19 11:44:20
Check Details
替诺福韦治疗乙肝效果优于恩替卡韦
2025-10-19 11:44:20
Check Details
1
2
...
103
104
105
106
107
108
109
...
504
505
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Is defibrotide included in medical insurance?
2
When was defibrinoside launched on the market?
3
Will defibrination be reimbursed by medical insurance?
4
What conditions is defibrinoside suitable for treating?
5
What is the therapeutic effect of defibrotide?
6
How should defibrinoside be used?
7
What is the effect of defibrotide?
8
Defibrinoside Detailed Instructions
9
What is the effect of defibrination?
10
How effective is defibrotide in the treatment of hepatic veno-occlusive disease?
11
How effective is defibrotide in hepatic veno-occlusive disease?
12
What conditions can defibrotide treat?